This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Modernatx, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kimberly Ann Coughlan: Innovator in Biochemistry
Introduction
Kimberly Ann Coughlan is a prominent inventor based in Watertown, MA (US). She has made significant contributions to the field of biochemistry, particularly in the treatment of metabolic disorders.
Latest Patents
Coughlan holds a patent for "Polynucleotides Encoding Branched-Chain Alpha-Ketoacid Dehydrogenase Complex E1-Alpha, E1-Beta, and E2 Subunits for the Treatment of Maple Syrup Urine Disease." This innovative work addresses a critical health issue and showcases her expertise in genetic engineering.
Career Highlights
Currently, Kimberly Ann Coughlan is associated with ModernaTX, Inc., where she continues to advance her research and development efforts. Her work at the company reflects her commitment to improving healthcare through innovative solutions.
Collaborations
Coughlan collaborates with notable professionals in her field, including her coworker Vladimir Presnyak. These partnerships enhance her research and contribute to the advancement of biochemistry.
Conclusion
Kimberly Ann Coughlan is a trailblazer in her field, with a focus on innovative treatments for metabolic diseases. Her contributions are paving the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile